Evaluation of MyoStrain™ in Clinical Practice



Status:Recruiting
Conditions:Lupus, Peripheral Vascular Disease, Cardiology, Cardiology, Endocrine, Hematology
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology, Hematology, Immunology / Infectious Diseases
Healthy:No
Age Range:Any
Updated:4/3/2019
Start Date:April 2019
End Date:February 1, 2020
Contact:Carissa Walter, MPH
Email:cwalter2@kumc.edu
Phone:913-945-7450

Use our guide to learn which trials are right for you!

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice to determine how the use
may alter treatment decisions and clinical outcomes in patients who are undergoing cardiac
MRI.

Inclusion Criteria:

- Patients already scheduled for diagnostic testing with commercially available imaging
modality (cardiac MRI)

- The patient population will include (but not limited to), those being evaluated for
heart disease and heart failure that may be related to vascular disease (coronary
artery disease), drug related heart failure (chemotherapy, alcohol), inflammatory
systemic conditions (sarcoidosis, amyloidosis, lupus), myocarditis, and/or infectious
etiologies

- Provided written informed consent

Exclusion Criteria:

- Contraindication to Magnetic Resonance Imaging
We found this trial at
1
site
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
Phone: 913-945-7450
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials